Aspirin May Reduce Ovarian Cancer Risk

Published Online: Wednesday, June 11, 2014
Follow Pharmacy_Times:
Women who take aspirin regularly may be at a reduced risk for ovarian cancer, the results of a meta-analysis suggest. The study, published online on February 6, 2014, in the Journal of the National Cancer Institute, analyzed data from population-based studies to help determine the association between the use of aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, and acetaminophen and the risk of developing ovarian cancer. The results indicated that regular aspirin use was associated with a reduced risk of ovarian cancer. Among 7 studies that reported frequency of use, daily use of aspirin was associated with a 20% decrease in ovarian cancer risk. In 3 studies that included dose information, low-dose aspirin use (less than 100 mg per day) was associated with a 34% reduction in ovarian cancer risk.

Related Articles
Not every patient requires an aspirin a day.
Olaparib treats women with advanced ovarian cancer associated with defective BRCA genes.
A Maine pharmacy tech has pleaded guilty to stealing drugs and falsifying records, after he was caught on camera taking handfuls of pills.
In healthy women, the cons of taking daily low-dose aspirin to prevent heart disease, cancer, and other serious illness outweigh the pros.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$